{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:54:11Z","timestamp":1781711651844,"version":"3.54.5"},"reference-count":12,"publisher":"Norwegian Medical Association","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.24.0173","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T16:45:52Z","timestamp":1745253952000},"source":"Crossref","is-referenced-by-count":0,"title":["Persistent use of high-dose opioids and other addictive medications"],"prefix":"10.4045","volume":"145","author":[{"given":"Line","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter C.","family":"Borchgrevink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Skurtveit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"ref=1","unstructured":"Helsedirektoratet. Vanedannende legemidler. Opioider. https:\/\/www.helsedirektoratet.no\/veiledere\/vanedannende-legemidler\/opioider Lest 4.8.2024."},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Hamina\u00a0A, Odsbu\u00a0I, Hjellvik\u00a0V et al. Fatal drug overdoses in individuals treated pharmacologically for chronic pain: a nationwide register-based study. Br J Anaesth 2024; 132: 86\u201395. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37953201&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.bja.2023.10.016","DOI":"10.1016\/j.bja.2023.10.016"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Dowell\u00a0D, Ragan\u00a0KR, Jones\u00a0CM et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep 2022; 71: 1\u201395. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36327391&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.15585%2Fmmwr.rr7103a1","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"ref=4","unstructured":"Helsedirektoratet. Rundskriv til ftrl \u00a7 5-14: Legemidler. https:\/\/lovdata.no\/nav\/rundskriv\/r05-14-02#KAPITTEL_3-11 Lest 10.2.2025."},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Odsbu\u00a0I, Handal\u00a0M, Hjellvik\u00a0V et al. Vedvarende bruk av opioider og samtidig bruk av andre vanedannende legemidler. Tidsskr Nor Legeforen 2022; 142. doi: 10.4045\/tidsskr.21.0659. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35170913&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4045%2Ftidsskr.21.0659","DOI":"10.4045\/tidsskr.21.0659"},{"key":"ref=6","unstructured":"Hamina\u00a0A, Muller\u00a0AE, Clausen\u00a0T et al. Prescription opioids among older adults: ten years of data across five countries. BMC Geriatr 2022; 22: 429. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35578167&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1186%2Fs12877-022-03125-0"},{"key":"ref=7","unstructured":"Helsedirektoratet. Ekvipotens av opioiddoser. https:\/\/www.helsedirektoratet.no\/veiledere\/vanedannende-legemidler\/pasientinformasjon-og-verktoy\/konvertering-av-opioiddoser Lest 20.10.2024."},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Svendsen\u00a0K, Skurtveit\u00a0S, Romundstad\u00a0P et al. Differential patterns of opioid use: defining persistent opioid use in a prescription database. Eur J Pain 2012; 16: 359\u201369. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22337119&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fj.1532-2149.2011.00018.x","DOI":"10.1002\/j.1532-2149.2011.00018.x"},{"key":"ref=9","unstructured":"Statistisk Sentralbyr\u00e5. Folketall. https:\/\/www.ssb.no\/befolkning\/folketall Lest 10.2.2025."},{"key":"ref=10","unstructured":"Universitetet i Oslo. POINT - Hvordan unng\u00e5 en opioidepidemi i Norge: Fokus p\u00e5 behandling av kroniske smerter. https:\/\/www.med.uio.no\/klinmed\/forskning\/prosjekter\/point-hvordan-unnga-opioidepidemi-norge\/ Lest 2.11.2024."},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Jann\u00a0M, Kennedy\u00a0WK, Lopez\u00a0G. Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics. J Pharm Pract 2014; 27: 5\u201316. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24436437&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177%2F0897190013515001","DOI":"10.1177\/0897190013515001"},{"key":"ref=12","unstructured":"Borchgrevink PC, Westgaard TE, Schj\u00f8dt B et al. Behov for felles innsats mot opioidproblemene. Dagens medisin 31.1.2023. https:\/\/www.dagensmedisin.no\/kroniske-smerter-legemidler-opioider\/behov-for-felles-innsats-mot-opioidproblemene\/511022 Lest 10.2.2025."}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Vedvarende bruk av h\u00f8ye doser opioider og andre vanedannende legemidler"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:22:03Z","timestamp":1781709723000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2025\/04\/kort-rapport\/vedvarende-bruk-av-hoye-doser-opioider-og-andre-vanedannende-legemidler"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":12,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,22]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.24.0173","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]}}}